Administrative and Coordinating Core
Administrative and Coordinating Core
批准号:
10601388
负责人:
MARGARET M MADELEINE
金额:
$20.96万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-18 至 2024-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY – ADMINISTRATIVE AND COORDINATING CORE (ACC)
The overarching goal of the Administrative and Coordinating Core (ACC) is to provide effective leadership to
optimize the successful accomplishment of the scientific aims of the Cervical Cancer Prevention
Partnership (C2P2) Center in Peru and the Dominican Republic. The management team for the ACC includes
three investigators: a Peru-based investigator, Dr. Robinson Cabello, MPI, and two Seattle-based
investigators, Dr. Duerr (MPI and Co-Chair Trial 1) and Dr. Madeleine (Contact MPI, Co-Investigator Trials 2
and 3). Together they will provide scientific direction, enhance productivity, liaise with the NCI, and monitor
safety, quality, recruitment, and progress toward each of the Aims of the Clinical Trials and service Cores. The
Aims of the ACC are as follows: Aim 1 of the ACC is to organize the C2P2 Center by distributing responsibility
and accountability throughout the C2P2 Center. The ACC will implement the Triple C (Communication,
Cooperation and Coordination) model of project management. This organizational approach will be grounded
in meeting regional needs and in respect for working with LAC partners who will lead and sustain the cutting-
edge changes we develop together through integrated and interdisciplinary team science. Aim 2 is to facilitate
communication and scheduling at all levels of the partnership. The ACC will foster high-level and bi-
directional coordination and cooperation directly with unit leaders (Clinical Trial Co-Chairs and service Core
Leaders) across the C2P2 Center (i.e., Core teams, Clinical Trial teams, institutions), and with external
advisors (i.e., External Scientific Advisory Group and the cross-cutting Partnership Center Coordinating
Committee). Aim 3 of the ACC is to lead all trial monitoring and regulatory coordination activities with the
assistance of the Data Coordinating Core. The first priority of the ACC is patient safety at both trial sties. Aim 4
of the ACC will provide training and dissemination of findings. The ACC will administratively support the
Clinical Trial Co-Chairs through cross-institutional training as needed to refine laboratory assay quality control,
data management skills training, and streamlined organizational infrastructure building that will enhance the
success of the matrixed partnership. All trial findings will be disseminated through published papers and
presentations in the region and at international meetings of policy and guideline makers who will be able to use
our trial findings to accelerate progress toward elimination of cervical cancer through prevention. The ACC will
provide leadership to accomplish the overall scientific goal of the C2P2 Center to improve the quality and
efficiency of cervical cancer prevention in the region.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Trials Program
-
批准号:10020373
-
项目类别:
-
资助金额:$53.27万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Clinical Trials Program
-
批准号:10224783
-
项目类别:
-
资助金额:$19.96万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Administrative and Coordinating Core
-
批准号:10224782
-
项目类别:
-
资助金额:$12.92万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Clinical Trials Program
-
批准号:10470116
-
项目类别:
-
资助金额:$5.64万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Administrative and Coordinating Core
-
批准号:10689735
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Administrative and Coordinating Core
-
批准号:10020372
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Clinical Trials Program
-
批准号:10601389
-
项目类别:
-
资助金额:$25.72万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Administrative and Coordinating Core
-
批准号:10470114
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Clinical Trials Program
-
批准号:10689736
-
项目类别:
-
资助金额:$40.16万
-
财政年份:2019
-
负责人:MARGARET M MADELEINE
-
依托单位:
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
-
批准号:9220396
-
项目类别:
-
资助金额:$76.78万
-
财政年份:2017
-
负责人:MARGARET M MADELEINE
-
依托单位:
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
-
批准号:10098635
-
项目类别:
-
资助金额:$13.42万
-
财政年份:2017
-
负责人:MARGARET M MADELEINE
-
依托单位:
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
-
批准号:10230257
-
项目类别:
-
资助金额:$25.14万
-
财政年份:2017
-
负责人:MARGARET M MADELEINE
-
依托单位:
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
-
批准号:10113554
-
项目类别:
-
资助金额:$22.72万
-
财政年份:2017
-
负责人:MARGARET M MADELEINE
-
依托单位:
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
-
批准号:10359814
-
项目类别:
-
资助金额:$78.07万
-
财政年份:2017
-
负责人:MARGARET M MADELEINE
-
依托单位:
Post GWA Analysis of Inflammation Pathways in Barrett's and Esophageal Cancer
-
批准号:8702512
-
项目类别:
-
资助金额:$22.0万
-
财政年份:2014
-
负责人:MARGARET M MADELEINE
-
依托单位:
BIOSTATISTICS AND DATA MANAGEMENT
-
批准号:8307531
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2011
-
负责人:MARGARET M MADELEINE
-
依托单位:
EPIDEMIOLOGY OF HPV-RELATED SCSC IN TRANSPLANT PATIENTS
-
批准号:8307527
-
项目类别:
-
资助金额:$43.17万
-
财政年份:2011
-
负责人:MARGARET M MADELEINE
-
依托单位:
Inflammation Pathways in Breast Cancer
-
批准号:7212734
-
项目类别:
-
资助金额:$38.27万
-
财政年份:2007
-
负责人:MARGARET M MADELEINE
-
依托单位:
BIOSTATISTICS AND DATA MANAGEMENT
-
批准号:7305823
-
项目类别:
-
资助金额:$29.33万
-
财政年份:2007
-
负责人:MARGARET M MADELEINE
-
依托单位:
Inflammation Pathways in Breast Cancer
-
批准号:7663814
-
项目类别:
-
资助金额:$56.79万
-
财政年份:2007
-
负责人:MARGARET M MADELEINE
-
依托单位:
海外基金